Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. [electronic resource]
Producer: 19970404Description: 117-21 p. digitalISSN:- 0921-299X
- Adjuvants, Immunologic -- adverse effects
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung -- pathology
- Combined Modality Therapy
- Female
- Humans
- Immunotherapy
- Longitudinal Studies
- Lung Neoplasms -- pathology
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Transfer Factor -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.